NFKB1 and rheumatoid arthritis: Since both umbeliferone and scopoletin had high binding affinities towards RA-FLS membrane proteins (Table 1) and inhibited RA-FLS activities (Figure 3), it is believed that NF-κB is a primary node of the two compounds in treating RA.